Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy.
Hakyoung KimHongseok YooHongryull PyoYong Chan AhnJae Myoung NohSang Gyu JuWoojin LeeByoungsuk ParkJin Man KimNoeul KangSun Hye ShinMan Pyo ChungSumin ShinHye Seung KimMinsu ParkHye Yoon ParkPublished in: International journal of chronic obstructive pulmonary disease (2019)
Definitive radiotherapy may be a tolerable treatment for early-stage NSCLC with COPD. However, poor survival in early-stage NSCLC patients with IPF or CPFE requires further study to identify and develop patient selection criteria as well as an optimal radiotherapy modality.
Keyphrases
- early stage
- small cell lung cancer
- sentinel lymph node
- locally advanced
- advanced non small cell lung cancer
- chronic obstructive pulmonary disease
- pulmonary hypertension
- idiopathic pulmonary fibrosis
- radiation therapy
- brain metastases
- rectal cancer
- cystic fibrosis
- epidermal growth factor receptor
- lymph node
- tyrosine kinase
- air pollution
- smoking cessation